<DOC>
	<DOC>NCT00684619</DOC>
	<brief_summary>The purpose of this study is to determine whether Nelarabine is effective in the treatment of patients with T-ALL/NHL in order to achieve a complete remission followed by an early stem cell transplantation.</brief_summary>
	<brief_title>506U78 In Relapsed Or Refractory Acute Lymphoblastic Leukemia (T-ALL)</brief_title>
	<detailed_description />
	<mesh_term>Precursor T-Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<criteria>TALL; TNHL age &gt;= 18 years cytological treatment failure / relapse molecular treatment failure / relapse no promising therapy alternatives with approved medication available no CNSmanifestation, requiring intrathecal therapy or CNSradiation no convulsive disease or neurotoxicity &gt; grade III in patients history written informed consent no cytostatic therapy in the last 10 days no pregnancy or breastfeeding effective contraception recovery of toxicities of previous chemotherapy except leukemia related changes like bone marrow suppression or pathological transaminases in liver manifestation Severe psychiatric illness uncontrolled or severe cardiac disease or infection active secondary neoplasms except skin cancer (no melanoma)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
</DOC>